Shareholders that lost money on regeneron pharmaceuticals, inc. (regn) should contact the gross law firm about pending class action - regn

New york, feb. 20, 2025 (globe newswire) -- the gross law firm issues the following notice to shareholders of regeneron pharmaceuticals, inc. (nasdaq: regn).
REGN Ratings Summary
REGN Quant Ranking